Research and development, production, regulation and market considerations for the next generation of biosimilar medicines
 |
 
|
Learn, partner, promote
World Biosimilar Congress 2013 is a proven conference and exhibition bringing together buyers and sellers from across the biosimilar an biobetter industry.
The event is Europe’s logical event for Biotech and Pharma players looking to engage in biosimilar drug development and learn from and do business with existing players and new entrants in this growing industry.
More on exhibiting ›
More on attending ›
The track record
- Over 120 pioneers and opinion leaders attended in 2012
- 53% of attendees were of pharma, biotech or academic origin
- 50% of attendees were C-Level, Executive, Director or Manager level
- 14+ countries represented onsite from across Europe, North America and Asia
- Over 600 onsite 1-2-1 meetings facilitated
Learn and innovate
- 25+ speakers in 2013
- 20+ educational sessions
- 8+ roundtable discussions
- 3 super keynote sessions
- 2 practical workshops
Pursue and partner
- 800+ partnering meetings in 3 days
- 175+ companies in the Total BioPharma Partnering system
- 1-2-1 Speed Networking sessions
- 2 engaging networking lunches and 1 social evening function
- Co-located with 9th European Antibody Congress
Raise and promote
- Commercial platforms to educate and lead
- 12 exhibition opportunities
- 25+ biosimilar research posters
- 8hrs+ of dedicated customer face time
- Access to bespoke marketing channels
Let us give you an edge
If you’d like to become an exhibitor sponsor or speaker at next year’s event call Derek Cavanagh on +44 (0) 207 092 1297 or email derek.cavanagh@terrapinn.com
Download more information ›
View the floorplan here >
sponsors
Gold Sponsor
Silver Sponsor
Silver Sponsor
co-located with
